Back to Polar Capital Holdings Plc Polar Capital Holdings Plc

ELVN

9 quarters

Position history for Polar Capital Holdings PlcPolar Capital Holdings Plc's holdings in Enliven Therapeutics, Inc.

Yes. Polar Capital Holdings holds 6,430,636 shares of ELVN (Enliven Therapeutics), worth $326.4M, as of its Q2 2026 13F filing. It increased the position by 1,364,703 shares (+26.9%) from Q1 2026. Polar Capital Holdings has held ELVN since Q2 2024, across 9 quarterly 13F filings. ELVN is 0.8% of Polar Capital Holdings' reported 13F portfolio.

Current Value

$326.4M

Current Shares

6.4M

Total Value Change

+$311.2M

Total Shares Change

+5.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
6.4M
+26.9%
$326.4M0.8%$50.75
54
2026-Q1
Increased
5.1M
+44.2%
$198.6M0.7%$28.75
58
2025-Q4
Increased
3.5M
+13.5%
$54.1M0.2%$15.55
40
2025-Q3
Increased
3.1M
+1.5%
$63.4M0.3%$20.30
36
2025-Q2
Increased
3.1M
+29.0%
$61.2M0.3%$20.68
44
2025-Q1
Decreased
2.4M
-1.0%
$46.5M0.3%$21.07
0
2024-Q4
Increased
2.4M
+267.6%
$53.8M0.3%$22.39
57
2024-Q3
Unchanged
650,000
0.0%
$16.6M0.1%$24.13
0
2024-Q2
New
650,000
-
$15.2M0.1%$23.37
39

Other major holders of ELVN: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used